Association of coffee consumption with risk of colorectal cancer: A meta-analysis of prospective cohort studies

Oncotarget

Volumn 8, Issue 12, 2017, Pages 18699-18711

  Gan, Yong ^a   Wu, Jiang ^b   Zhang, Shengchao ^b   Li, Liqing ^a,c   Cao, Shiyi ^a   Mkandawire, Naomie ^a   Ji, Kun ^d   Herath, Chulani ^a   Gao, Chao ^e   Xu, Hong ^a   Zhou, Yanfeng ^a   Song, Xingyue ^a   Chen, Shanquan ^f   Chen, Yawen ^a   Yang, Tingting ^a   Li, Jing ^a   Qiao, Yan ^a   Hu, Sai ^a   Yin, Xiaoxv ^a   Lu, Zuxun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Department of Neurology   (China)

^c JIANGXI SCIENCE AND TECHNOLOGY NORMAL UNIVERSITY   (China)

^d SHENYANG MEDICAL COLLEGE   (China)

^e CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^f CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Coffee; Colorectal cancer; Epidemiology; Meta analysis; Prospective cohort

Indexed keywords

ARTICLE; CANCER RISK; COFFEE; COLORECTAL CANCER; CONTROLLED STUDY; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; NEWCASTLE-OTTAWA SCALE; RISK ASSESSMENT; COHORT ANALYSIS; COLORECTAL TUMOR; DIET; META ANALYSIS; PROSPECTIVE STUDY; RISK FACTOR;

COFFEE; COHORT STUDIES; COLORECTAL NEOPLASMS; DIET; HUMANS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 85015777944     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.8627     Document Type: Article

References (56)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A. Global cancer statistics, 2012. CA: a cancer journal for clinicians. 2015; 65:87-108.
2. Kono S. Secular trend of colon cancer incidence and mortality in relation to fat and meat intake in Japan. Eur J Cancer Prev. 2004; 13:127-132.
3. Kolonel LN. Cancer patterns of four ethnic groups in Hawaii. Journal of the National Cancer Institute. 1980; 65:1127-1139.
4. Armstrong B and Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. International journal of cancer. 1975; 15:617-631.
5. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: American Institute for Cancer Research; 2011.
6. Lopez-Garcia E, van Dam RM, Qi L and Hu FB. Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. The American journal of clinical nutrition. 2006; 84:888-893.
7. Huxley R, Lee CM, Barzi F, Timmermeister L, Czernichow S, Perkovic V, Grobbee DE, Batty D and Woodward M. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with meta-analysis. Archives of internal medicine. 2009; 169:2053-2063.
8. Wu T, Willett WC, Hankinson SE and Giovannucci E. Caffeinated coffee, decaffeinated coffee, and caffeine in relation to plasma C-peptide levels, a marker of insulin secretion, in U.S. women. Diabetes care. 2005; 28:1390-1396.
9. Dorea JG and da Costa TH. Is coffee a functional food? The British journal of nutrition. 2005; 93:773-782.
10. Thomson CA and Martinez ME. Coffee, tea, what beverage for me? Associations between beverage intake and colorectal neoplasia risk. Journal of the National Cancer Institute. 2010; 102:749-751.
11. Food and Agricultural Organization. Food balance sheets. Accessed on Apr 2004. Available from: URL: http://www.fao.org/waicent/portal/statistics_en.asp.
12. Li G, Ma D, Zhang Y, Zheng W and Wang P. Coffee consumption and risk of colorectal cancer: a meta-analysis of observational studies. Public health nutrition. 2013; 16:346-357.
13. Jacobsen BK, Bjelke E, Kvale G and Heuch I. Coffee drinking, mortality, and cancer incidence: results from a Norwegian prospective study. Journal of the National Cancer Institute. 1986; 76:823-831.
14. Wu AH, Paganini-Hill A, Ross RK and Henderson BE. Alcohol, physical activity and other risk factors for colorectal cancer: a prospective study. British journal of cancer. 1987; 55:687-694.
15. Klatsky AL, Armstrong MA, Friedman GD and Hiatt RA. The relations of alcoholic beverage use to colon and rectal cancer. American journal of epidemiology. 1988; 128:1007-1015.
16. Stensvold I and Jacobsen BK. Coffee and cancer: a prospective study of 43,000 Norwegian men and women. Cancer causes & control: CCC. 1994; 5:401-408.
17. Hartman TJ, Tangrea JA, Pietinen P, Malila N, Virtanen M, Taylor PR and Albanes D. Tea and coffee consumption and risk of colon and rectal cancer in middle-aged Finnish men. Nutrition and cancer. 1998; 31:41-48.
18. Terry P, Bergkvist L, Holmberg L and Wolk A. Coffee consumption and risk of colorectal cancer in a population based prospective cohort of Swedish women. Gut. 2001; 49:87-90.
19. Michels KB, Willett WC, Fuchs CS and Giovannucci E. Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer. Journal of the National Cancer Institute. 2005; 97:282-292.
20. Larsson SC, Bergkvist L, Giovannucci E and Wolk A. Coffee consumption and incidence of colorectal cancer in two prospective cohort studies of Swedish women and men. American journal of epidemiology. 2006; 163:638-644.
21. Oba S, Shimizu N, Nagata C, Shimizu H, Kametani M, Takeyama N, Ohnuma T and Matsushita S. The relationship between the consumption of meat, fat, and coffee and the risk of colon cancer: a prospective study in Japan. Cancer letters. 2006; 244:260-267.
22. Naganuma T, Kuriyama S, Akhter M, Kakizaki M, Nakaya N, Matsuda-Ohmori K, Shimazu T, Fukao A and Tsuji I. Coffee consumption and the risk of colorectal cancer: a prospective cohort study in Japan. International journal of cancer. 2007; 120:1542-1547.
23. Lee KJ, Inoue M, Otani T, Iwasaki M, Sasazuki S and Tsugane S. Coffee consumption and risk of colorectal cancer in a population-based prospective cohort of Japanese men and women. International journal of cancer. 2007; 121:1312-1318.
24. Nilsson LM, Johansson I, Lenner P, Lindahl B and Van Guelpen B. Consumption of filtered and boiled coffee and the risk of incident cancer: a prospective cohort study. Cancer causes & control: CCC. 2010; 21:1533-1544.
25. Peterson S, Yuan JM, Koh WP, Sun CL, Wang R, Turesky RJ and Yu MC. Coffee intake and risk of colorectal cancer among Chinese in Singapore: the Singapore Chinese Health Study. Nutrition and cancer. 2010; 62:21-29.
26. Bidel S, Hu G, Jousilahti P, Antikainen R, Pukkala E, Hakulinen T and Tuomilehto J. Coffee consumption and risk of colorectal cancer. European journal of clinical nutrition. 2010; 64:917-923.
27. Simons CC, Leurs LJ, Weijenberg MP, Schouten LJ, Goldbohm RA and van den Brandt PA. Fluid intake and colorectal cancer risk in the Netherlands Cohort Study. Nutrition and cancer. 2010; 62:307-321.
28. Sinha R, Cross AJ, Daniel CR, Graubard BI, Wu JW, Hollenbeck AR, Gunter MJ, Park Y and Freedman ND. Caffeinated and decaffeinated coffee and tea intakes and risk of colorectal cancer in a large prospective study. The American journal of clinical nutrition. 2012; 96:374-381.
29. Perrigue MM, Kantor ED, Hastert TA, Patterson R, Potter JD, Neuhouser ML and White E. Eating frequency and risk of colorectal cancer. Cancer causes & control: CCC. 2013; 24:2107-2115.
30. Yamada H, Kawado M, Aoyama N, Hashimoto S, Suzuki K, Wakai K, Suzuki S, Watanabe Y and Tamakoshi A. Coffee consumption and risk of colorectal cancer: the Japan Collaborative Cohort Study. Journal of epidemiology. 2014; 24:370-378.
31. Dik VK, Bueno-de-Mesquita HB, Van Oijen MG, Siersema PD, Uiterwaal CS, Van Gils CH, Van Duijnhoven FJ, Cauchi S, Yengo L, Froguel P, Overvad K, Bech BH, Tjonneland A, Olsen A, Boutron-Ruault MC, Racine A, et al. Coffee and tea consumption, genotype-based CYP1A2 and NAT2 activity and colorectal cancer risk-results from the EPIC cohort study. International journal of cancer. 2014; 135:401-412.
32. Je Y, Liu W and Giovannucci E. Coffee consumption and risk of colorectal cancer: a systematic review and metaanalysis of prospective cohort studies. International journal of cancer. 2009; 124:1662-1668.
33. Tian C, Wang W, Hong Z and Zhang X. Coffee consumption and risk of colorectal cancer: a dose-response analysis of observational studies. Cancer causes & control: CCC. 2013; 24:1265-1268.
34. Rothwell K. Dose-related inhibition of chemical carcinogenesis in mouse skin by caffeine. Nature. 1974; 252:69-70.
35. Ivankovic S, Seibel J, Komitowski D, Spiegelhalder B, Preussmann R and Siddiqi M. Caffeine-derived N-nitroso compounds. V. Carcinogenicity of mononitrosocaffeidine and dinitrosocaffeidine in bd-ix rats. Carcinogenesis. 1998; 19:933-937.
36. Ding M, Bhupathiraju SN, Chen M, van Dam RM and Hu FB. Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a doseresponse meta-analysis. Diabetes care. 2014; 37:569-586.
37. Ferruzzi MG. The influence of beverage composition on delivery of phenolic compounds from coffee and tea. Physiology & behavior. 2010; 100:33-41.
38. Cavin C, Holzhaeuser D, Scharf G, Constable A, Huber WW and Schilter B. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association. 2002; 40:1155-1163.
39. Ding M, Bhupathiraju SN, Satija A, van Dam RM and Hu FB. Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a doseresponse meta-analysis of prospective cohort studies. Circulation. 2014; 129:643-659.
40. Gross G, Jaccaud E and Huggett AC. Analysis of the content of the diterpenes cafestol and kahweol in coffee brews. Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association. 1997; 35:547-554.
41. George SE, Ramalakshmi K and Mohan Rao LJ. A perception on health benefits of coffee. Critical reviews in food science and nutrition. 2008; 48:464-486.
42. Cardenas C, Quesada AR and Medina MA. Anti-angiogenic and anti-inflammatory properties of kahweol, a coffee diterpene. PloS one. 2011; 6:e23407.
43. Post SM, de Wit EC and Princen HM. Cafestol, the cholesterol-raising factor in boiled coffee, suppresses bile acid synthesis by downregulation of cholesterol 7 alphahydroxylase and sterol 27-hydroxylase in rat hepatocytes. Arteriosclerosis, thrombosis, and vascular biology. 1997; 17:3064-3070.
44. Ricketts ML, Boekschoten MV, Kreeft AJ, Hooiveld GJ, Moen CJ, Muller M, Frants RR, Kasanmoentalib S, Post SM, Princen HM, Porter JG, Katan MB, Hofker MH and Moore DD. The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors. Mol Endocrinol. 2007; 21:1603-1616.
45. Huber WW, Teitel CH, Coles BF, King RS, Wiese FW, Kaderlik KR, Casciano DA, Shaddock JG, Mulder GJ, Ilett KF and Kadlubar FF. Potential chemoprotective effects of the coffee components kahweol and cafestol palmitates via modification of hepatic N-acetyltransferase and glutathione S-transferase activities. Environmental and molecular mutagenesis. 2004; 44:265-276.
46. Huber WW and Parzefall W. Modification of N-acetyltransferases and glutathione S-transferases by coffee components: possible relevance for cancer risk. Methods in enzymology. 2005; 401:307-341.
47. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA and Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Jama. 2000; 283:2008-2012.
48. Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M and Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in metaanalyses. Available from www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 1 May 2014.
49. Hamling J, Lee P, Weitkunat R and Ambuhl M. Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Statistics in medicine. 2008; 27:954-970.
50. Greenland S and Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. American journal of epidemiology. 1992; 135:1301-1309.
51. Aune D, Lau R, Chan DS, Vieira R, Greenwood DC, Kampman E and Norat T. Dairy products and colorectal cancer risk: a systematic review and meta-analysis of cohort studies. Annals of oncology: official journal of the European Society for Medical Oncology /ESMO. 2012; 23:37-45.
52. Harrell FE, Jr., Lee KL and Pollock BG. Regression models in clinical studies: determining relationships between predictors and response. Journal of the National Cancer Institute. 1988; 80:1198-1202.
53. Orsini N, Li R, Wolk A, Khudyakov P and Spiegelman D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. American journal of epidemiology. 2012; 175:66-73.
54. Higgins JP and Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in medicine. 2002; 21:1539-1558.
55. Begg CB and Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50:1088-1101.
56. Egger M, Davey Smith G, Schneider M and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical research ed). 1997; 315:629-634.